Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
PERNIX THERAPEUTICS HOLDINGS, INC. (PTX)
|
|
Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
In millions, except per share items | Sep-30-18 | Jun-30-18 | Mar-31-18 | Dec-31-17 | Sep-30-17 | Jun-30-17 | Mar-31-17 | Dec-31-16 |
| 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Cost of goods sold | 31.8% | 26.4% | 31.8% | 32.5% | 26.1% | 30.6% | 33.8% | 30.0% |
Gross profit | 68.2% | 73.6% | 68.2% | 67.5% | 73.9% | 69.4% | 66.2% | 70.0% |
Selling, general and administrative | 96.5% | 94.6% | 100.4% | | 71.4% | 106.2% | 133.8% | |
Research and development | | | | | | | | |
General and administrative | | | | 127.0% | | | | 324.6% |
EBITDA | -21.8% | -14.1% | 2.9% | -190.4% | 47.6% | 16.3% | -5.1% | -498.9% |
Depreciation | 0.4% | 0.4% | 0.3% | 0.2% | 0.2% | 0.3% | 0.3% | 0.4% |
EBITA | -22.2% | -14.5% | 2.6% | -190.6% | 47.4% | 16.1% | -5.4% | -499.3% |
Amortization of intangibles | 6.1% | 6.5% | 34.8% | -131.9% | 44.9% | 52.9% | 62.2% | -215.0% |
EBIT | -28.3% | -21.0% | -32.2% | -58.7% | 2.5% | -36.8% | -67.6% | -284.3% |
Pre-tax income | -57.3% | -64.0% | -65.9% | -77.4% | 15.8% | -62.9% | -98.9% | -283.9% |
Income taxes | 0.2% | 0.0% | 0.1% | 0.6% | 0.1% | 0.1% | 0.2% | 1.4% |
Net income | -31.9% | 0.0% | 0.0% | 107.6% | 15.7% | 0.0% | 0.0% | 276.8% |
|